ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies for chronic migraine patients, ...

About one in ten people experience migraines, making it one of the most common forms of headaches. In 25% of cases, migraines ...

Migraines are complex, and their triggers can vary widely.” - Chaise BennettSLIDELL, LA, UNITED STATES, October 11, 202 ...

ShiraTronics announced today that it closed a $66 million Series B financing round to support its Migraine Therapy System.

Common migraine triggers include alcohol and hormone changes during the menstrual cycle or perimenopause. Lack of regularity ...

Migraine is characterised by a wide spectrum of clinical symptoms, including severe and persistent headaches often ...

A study has revealed triptans are the most effective medicine for adults experiencing acute migraine. Read more ...

After putting forward preliminary clinical data earlier this year from its neuromodulation implant for reducing chronic ...

The funding is set to be used to launch a new a multi-centre, blinded, randomised clinical trial designed to test the ...

Monthly erenumab induced remission of nonopioid medication overuse headache safely and effectively in patients with chronic ...

A Minnesota woman suffers a rare metabolic disorder known as acute intermittent porphyria – which causes her life-threatening ...